The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Activist investor Nelson Peltz has earned a huge win in his protracted battle of wills with Disney CEO Bob Iger.
A shortage of pressurized fuel tanks and electric batteries has significantly disrupted production.
Gucci’s parent company expects sales to slump by 10%, largely due to a downturn in Chinese demand.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
The British car maker said seven out of 10 customers spent more than $43,000 on customizing their new rides.
The company plans to have one of the newfangled small modular reactors up and running in Wyoming by 2030.
Why is Saudi Arabia spending a king’s ransom on sports? The Middle East powerhouse doesn’t care if you call it sportswashing.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Despite tariffs, the US imported a record number of panels through November of last year.
An insurance nonprofit found that claims about autonomous driving safety don’t measure up.
Southwest and Alaska said that the manufacturer’s uncertain status makes it hard to forecast the year ahead.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.